Kyowa Kirin is a global specialty pharmaceutical company dedicated to developing new drugs and antibody technologies to enhance human life.
BioWa, a member of the Kyowa Kirin Group, is committed to advancing life science through antibody-based technologies, including third party licensing.
ProStrakan, a subsidiary of Kyowa Kirin, is dedicated to commercializing specialty pharmaceuticals that address the unmet needs of patients with cancer and the healthcare professionals who care for them.
Biotechnology Cancer/Chemotherapy Human Biologicals Immunotherapy Monoclonal Antibodies Oncology Pharmaceuticals Pharmaceuticals
Copyright 2013-14 © a2z, Inc. All rights reserved.